Clinical Trial Update: A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A [Phase 1]

View source ↗

Summary

This update describes a Phase 1 clinical trial evaluating different doses of Inno8 in participants with Hemophilia A to study how the drug behaves in the body.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Inno8

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia A | Phase 1 | Status: RECRUITING